| Identification | Back Directory | [Name]
Transdermal Peptide | [CAS]
918629-48-8 | [Synonyms]
TTD-1
Transdermal Peptide
Transdermal peptide 1, TD-1
Transdermal Peptide USP/EP/BP
Glycine, L-alanyl-L-cysteinyl-L-seryl-L-seryl-L-seryl-L-prolyl-L-seryl-L-lysyl-L-histidyl-L-cysteinyl- | [Molecular Formula]
C40H66N14O16S2 | [MDL Number]
MFCD09263396 | [MOL File]
918629-48-8.mol | [Molecular Weight]
1063.17 |
| Chemical Properties | Back Directory | [Boiling point ]
1710.6±65.0 °C(Predicted) | [density ]
1.450±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [pka]
3.20±0.10(Predicted) | [Water Solubility ]
Soluble in Water |
| Hazard Information | Back Directory | [Uses]
TD-1 (Transdermal peptide) is a short peptide that can promote the delivery of macromolecule drugs, especially protein drugs, through the skin barrier. TD-1 can significantly improve the transdermal delivery efficiency of protein drugs such as insulin and human growth hormone, allowing them to reach systemic circulation. Research on TD-1 transdermal drug delivery system[1]. | [References]
[1] Chen Y, et al. Transdermal protein delivery by a coadministered peptide identified via phage display[J]. Nature biotechnology, 2006, 24(4): 455-460. DOI:10.1038/nbt1193 |
|
|